Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any colorectal cancer in which the cause of the disease is a mutation in the POLE gene.
Features include: Carcinoma and Colorectal polyposis.
Biomarker and diagnostic research for colorectal cancer, susceptibility to, 12 has been reported in the published literature.
No clinical trials have been registered for colorectal cancer, susceptibility to, 12.
233 publications have been identified in PubMed for colorectal cancer, susceptibility to, 12. Kisho has analyzed 111 by research type. Research spans Epidemiology / Natural History (41%), Basic Science / Preclinical (32%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 46 | 41% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 10:56 AM UTC
Online Mendelian Inheritance in Man
Common questions about colorectal cancer, susceptibility to, 12
Laboratory research |
36 |
32% |
Research summaries | 14 | 13% |
Testing and diagnosis research | 10 | 9% |
Patient case studies | 2 | 2% |
New treatment approaches | 2 | 2% |
Clinical study results | 1 | 1% |
Zhu F (2026). [PMID: 42113310](https://pubmed.ncbi.nlm.nih.gov/42113310/). *Inflamm Res*. [Basic Science / Preclinical]
Chen E (2026). [PMID: 41719390](https://pubmed.ncbi.nlm.nih.gov/41719390/). *Sci Adv*. [Review / Meta-Analysis]
Baltayev N (2026). [PMID: 41981019](https://pubmed.ncbi.nlm.nih.gov/41981019/). *Sci Rep*. [Epidemiology / Natural History]
Liu J (2026). [PMID: 41688208](https://pubmed.ncbi.nlm.nih.gov/41688208/). *Zhonghua Zhong Liu Za Zhi*. [Diagnostic / Biomarker]
Wang J (2026). [PMID: 42104324](https://pubmed.ncbi.nlm.nih.gov/42104324/). *BMC Cancer*. [Epidemiology / Natural History]
Xiang S (2026). [PMID: 42107035](https://pubmed.ncbi.nlm.nih.gov/42107035/). *J Cancer Res Clin Oncol*. [Review / Meta-Analysis]
Xie H (2026). [PMID: 41731847](https://pubmed.ncbi.nlm.nih.gov/41731847/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Zhang M (2026). [PMID: 41786212](https://pubmed.ncbi.nlm.nih.gov/41786212/). *Mod Pathol*. [Epidemiology / Natural History]
Sánchez-Maldonado JM (2026). [PMID: 41813586](https://pubmed.ncbi.nlm.nih.gov/41813586/). *Int J Cancer*. [Review / Meta-Analysis]
Asmanidou S (2026). [PMID: 41620400](https://pubmed.ncbi.nlm.nih.gov/41620400/). *Cell Death Dis*. [Gene Therapy / Novel Therapeutics]